What is the clinical evidence from this study?

Study design: Observational. Population: Critical, drug-resistant arrhythmias (n=40). Intervention: Intravenous amiodarone. Primary outcome: Efficacy and safety (successful treatment of tachyarrhythmias).

What does this research mean for the field?

Intravenous amiodarone is safe and effective for treating critical, drug-resistant tachyarrhythmias in pediatric patients, particularly for postoperative junctional ectopic tachycardia. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

Evaluate the clinical efficacy, electrophysiological response, and safety outcomes associated with a standardized intravenous amiodarone protocol in critically ill pediatric patients.

September 17, 2026Journal of the American College of CardiologyOpen Access

Pediatric use of intravenous amiodarone: Efficacy and safety in critically III patients from a multicenter protocol

View Full Paper

Ask AI

Bookmark

Key result

IV amiodarone successfully treats critical drug-resistant tachyarrhythmias in young patients, with ~23% non-drug mortality.

n=40

Why the study?

Experience with intravenous amiodarone in young patients was limited, and a larger pediatric study was needed to provide responsible guidelines before its market release.

Population

Forty young patients with critical, drug-resistant arrhythmias

Comparison

Intravenous amiodarone

Design

Multicenter protocol study

Authors

JPJames C. PerryUniversity of San Diego AFArnold L. FenrichLiaquat National Hospital JHJ. Edward HulseHenrietta Egleston Hospital for Children

Discussion

Member takes

Implication

Multicenter protocol study demonstrates the efficacy and safety of intravenous amiodarone in critically ill children, highlighting its clinical value for acute tachyarrhythmias.

Key Points

Evaluate the clinical efficacy, electrophysiological response, and safety outcomes associated with a standardized intravenous amiodarone protocol in critically ill pediatric patients.
Implemented a standardized multicenter intravenous amiodarone dosing and infusion protocol across pediatric intensive care settings.
Monitored acute conversion rates, hemodynamic parameters, and treatment-related complications during intravenous administration.
Intravenous amiodarone successfully achieved acute rate control and rhythm conversion across treated pediatric patients with critical tachyarrhythmias.
Hemodynamic adverse effects, primarily transient hypotension and bradycardia, were observed and managed under the protocolized monitoring framework.

Study Design

Type

Observational (n=40)

Multicenter

Yes

PICO

Population

40 young patients with critical, drug-resistant arrhythmias in whom standard management failed.

Exposure / Comparator

Intravenous amiodarone (Average loading dose 6.3 mg/kg body weight)

Primary Outcome

Efficacy and safety (successful treatment of tachyarrhythmias)

Cite This Study

Perry et al. (1996) conducted an observational in Critical, drug-resistant arrhythmias (n=40). Intravenous amiodarone was evaluated on Efficacy and safety (successful treatment of tachyarrhythmias). Intravenous amiodarone successfully treated critical, drug-resistant tachyarrhythmias in young patients, with 9 of 40 patients (23%) dying from causes not attributed to the drug.

synapsesocial.com/papers/6aab5b7628c522ff1f5d4dd0 https://doi.org/10.1016/0735-1097(95)00591-9

View Full Paper

Ask AI

Bookmark

Implication

Multicenter protocol study demonstrates the efficacy and safety of intravenous amiodarone in critically ill children, highlighting its clinical value for acute tachyarrhythmias.

Pediatric use of intravenous amiodarone: Efficacy and safety in critically III patients from a multicenter protocol

Discussion

Member takes

Implication

Key Points

Study Design

PICO

Cite This Study

Pediatric use of intravenous amiodarone: Efficacy and safety in critically III patients from a multicenter protocol

Discussion

Member takes

Implication

Key Points

Study Design

PICO

Cite This Study

Also Consider

Also Consider